Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 48 for “"New Drug Development"”.
-
Proteomic analysis of airway inflammation in murine asthma models
… of asthma. Our findings would shed new light on the exploration of new mechanisms of the development of asthma and identification of potential biomarkers and potential therapeutic targets for asthma. Moreover, our pharmacoproteomics study further broadens our understanding of the …
-
Characterize the anti-HIV-1 activity of a kinase inhibitor kenpaullone and the HIV-1 integrase association with DIC1 and DYNLT1
… it is still necessary to develop anti-HIV-1 new drugs. In this study, two projects were conducted and may contribute to the new drug development. The first project is focused on characterizing the anti-HIV activity of a kinase inhibitor Kenpaullone (Ken). We found a cyclin dependent kinase …
-
Measures that matter : vendor performance in outsourced bioequivalence studies
Outsourcing clinical research (R&D) and development to specialised contract research organisations (CROs) is common in the pharmaceutical industry and while these practices and characteristics of sponsor-vendor relationships have been widely studied in the context of new drug development, little …
-
QUB-1453: A Bioactive Peptide from the Defensive Skin Secretion of Rana amurensis
… potent bioactivity and pharmaceutical value for new drug development. In this thesis, QUB-1452, an AMP, was isolated and characterised from the skin secretion of Rana amurensis. The peptide is composed of 13 amino acid residues, FLPVLISLIGRLL, and is C-terminally amidated. The structure and …
-
Targeting Oncogenic Mirnas With Small Molecules For Breast Cancer Therapy
… pathobiology has driven the introduction of new drug development approaches such as miRNA inhibition. In order to advance miRNA-therapeutics, there is a need to develop screening strategies that can target tumors in a specific way. Small molecule inhibitors represent an attractive approach to …
-
A bioactive peptide from the defensive skin secretion of <i>Odorrana versabilis</i>
… The bioactive peptides could play a key role in new drug development. In this thesis, a bioactive peptide named QUB-1966, was isolated and characterised from the skin secretion of the Chinese Ranidae frog, Odorrana versabilis. The peptide consisted of 21 amino acid residues, …
-
Structural characterization of UDP-galactopyranose mutase from eukaryotic pathogens
… that are either highly toxic or expensive. Thus, new drug development strategies are required for combating these lethal diseases. The unique chemistry of UGMs and its implication in the virulence of pathogenic bacteria, fungi and protozoa and its absence in humans make it a potential drug target. …
-
Nonribosomal Peptide Identification with Tandem Mass Spectrometry by Searching Structural Database
… as novel NRPs are often promising substances for new drug development. To effectively discover novel NRPs from microbial fermentations, a crucial step is to identify known NRPs in an early stage and exclude them from further investigation. This so-called dereplication step ensures the scarce …
-
Nonribosomal Peptide Analog Identification with Tandem Mass Spectrometry
… novel NRPs are often promising substances for new drug development. To discover novel NRPs with limited resources from microbial fermentations, a significant process is to identify known NRPs and their analogs in an early stage and exclude them from further investigation. This so-called …
-
DEVELOPING MULTI-OMICS ANALYSIS PIPELINE TO IDENTIFY NOVEL DRUG REPURPOSING TARGETS FOR COPD
… stop the progressive decline in lung function. Drug repurposing is the application of existing approved therapeutic compounds for new disease indications, which may reduce the cost and time of new drug development. So far, there is not any systematic multi-omics data integration for drug …
-
Patent landscape reporting quality and predicting drug approval
… is a major contributor to the cost of new drug development. Therefore, the ability to predict drug approval could improve R&D; efficiency. The success of drug development programs is governed both by scientific factors and by “external” factors, such as intellectual property, company …
-
A novel two-component signal transduction system in propionibacterium acnes and its association with a putative extracellular signalling peptide
… of human skin, is thought to be involved in the development of inflammatory acne, which is an exclusive human disease affecting more than 80% of the whole population. Quorum sensing is the regulation of gene expression in response to cell density. As it is often involved in pathogenecity of …
-
Towards Personalized Medicine: Computational Approaches For Drug Repurposing And Cell Type Identification
The traditional drug discovery process is extremely slow and costly. More than 90% of drugs fail to pass beyond the early stage of development and toxicity tests, and many of the drugs that go through early phases of the clinical trials fail because of adverse reactions, side effects, or lack of …
-
Plasmodium falciparum lipid metabolism as a target for malaria intervention strategies
… in the world despite years of sustained effort, new drug development, and a greater understanding of the causative parasite, Plasmodium, and its interactions with its host. The resistance of Plasmodium parasites to frontline drug treatments is driving an increase in deaths from malaria, …
-
Electrochemically controlled interaction of liposomes with a solid-supported octadecanol bilayer
… proteins and ion channels are a major target for new drug development. Incorporating them into sensors requires a method to produce stable, easily modifiable solid-supported phospholipid bilayers. This thesis demonstrates a method for using potential control on the electrode to mediate liposome …
-
THE TIMING AND TYPE OF ALLIANCE PARTNERSHIPS IN THE NEW PRODUCT DEVELOPMENT PROCESS
… the ability of firms to effectively manage their new product innovation in the face of disruptive technological changes, increased global competition, and rising costs of research and development. These concerns notwithstanding, firms are additionally required to launch radical new products to the …
-
Predicting Toxin-Antitoxin Systems Responsible for Host-Induced Persistence of Burkholderia pseudomallei
… and targeting them provides an avenue for new drug development to reduce chronic infection. When investigating TAS, the predominant issue is the presence of a large number of TAS in an organism. Currently, there is no predictive model to determine which conditions toxins respond to. Because …
-
Modulation of Human and Malarial Glucose Transporter Activity by Lipids and Small Molecules
… PfHT has been extensively validated as drug target for different parasitic life stages in vitro and in animal models. The emergence of parasites with resistance to even the most potent existing anti-malarial drugs has made paramount the development of novel drugs that target essential …
-
Identification of compounds inhibiting a Leishmania RNA editing reaction.
… to the parasites is an attractive target for new drug development. The editing reaction involves the post-transcriptional modification of specific mitochondrial mRNAs through the precise deletion or insertion of uridylates. Many aspects of the editing mechanism are still unclear, and the lack …
-
Schistosoma Mansonii aspartic protease expression and refolding trials
… with resistance emergence to praziquantel, the drug of choice for treatment, being reported in recent years. Thus, new chemotherapeutic targets are been investigated, aiming to develop drugs that are more effective, with lower cost and fewer adverse reactions. Among these new targets, aspartic …
Page 1 of 3